Abstract
Introduction
Infantile hemangiomas (IHs) are the most common vascular tumor of childhood, affecting 5% to 10% of all infants. If left untreated, these tumors are characterized by a rapid growth phase during the first year of life, followed by slow involution, which may continue until the age of 7-10 years [1] . In 10% of cases, IHs grow dramatically and destroy tissue, impair function or even threaten life [2, 3] .
In proliferating IHs, one of the most important characteristics of vascular remodeling is the abundance of endothelial cells (ECs) and pericytes, both of which form nascent vessels with irregular lumens that are associated with high blood flow [4, 5] . In contrast, involuting IHs have less cellular density but are characterized by prominent well-formed vascular channels or lumens, combined with a severe reduction of blood flow [6, 7] . The appearance of well-organized luminal structures imply that IHs become 'more mature' at the involuting phase [8] .
Pericytes are derived from the mesenchyme and present within the basement membrane of blood vessels. In contrast to vSMCs, pericytes are directly embedded within the endothelial basement membrane. Quiescent pericytes/vSMCs are fully differentiated, non-proliferative cells that express high levels of a subset of genes required for their contractile functions [9] . Interestingly, recent data have offered evidence that proliferating hemangioma-derived pericytes (Hem-pericytes) are distinct from involuting Hem-pericytes at both the transcriptional and functional levels [10] . These contrasting studies revealed that proliferating Hem-pericytes exhibit altered angiogenic cytokines and acquire altered phenotypes to adapt to the abnormal physical environment of the tumor by undergoing a form of reprogramming that involves an increase in proliferation and a decrease in contractility [10, 11] . However, the molecular mechanisms of IH involution that are associated with Hempericyte maturation from the proliferating phase to the involuting phase have not been completely elucidated.
The Notch pathway is a conserved ligand-receptor signaling pathway that plays a prominent role in cell fate, including proliferation, differentiation, and maturation [12] . It has been suggested that Notch signaling is silent during the early stages of angiogenesis (when active vascular cell proliferation is required) but activated during vessel maturation (when vascular cells cease proliferation and likely undergo maturation-associated cell cycle arrest) [9, 13] . These data support the hypothesis that Notch signaling helps control vessel homeostasis by maintaining vascular cell quiescence.
Current data suggest that several Notch components are involved in the pathogenesis of IH [14] [15] [16] [17] . Remarkably, recent studies have revealed that endothelial-derived Jagged1 can induce hemangioma-derived stem cells (HemSCs) to acquire a pericyte-like phenotype, which is a crucial step in the vasculogenesis of IH. Disruption of the juxtacrine interaction between endothelial Jagged1 and Notch receptors on HemSCs inhibits blood vessel formation in IH murine models [18] .
Herein, we report on a series of studies that were performed to determine whether Notch signaling could influence the Hem-pericyte phenotype. Our findings demonstrate that Jagged1 activation of Notch3 signaling blocks cell proliferation and induces the expression of vascular smooth muscle contractile markers in Hem-pericytes. Our data describe a novel pro-quiescence function for Jagged1/Notch3 signaling in Hem-pericytes.
Materials and Methods

Cell extraction and isolation
This study was approved by the Ethics Committee of the West China Hospital of Sichuan University. Written informed consent was obtained from the patient's parents for all tissues obtained for the study, according to the Declaration of Helsinki. The characteristics of the patients are list in Table 1 .The clinical diagnosis of IHs was confirmed in the Department of Pathology. Single-cell suspensions were prepared from IH specimens [19, 20] , and Hem-pericyte isolation was performed as previously described [21] . Briefly, hemangioma tissue was transferred on ice immediately after resection, and was quickly minced into 1-2 mm 3 specimens. Rinsed the pieces of tissues with PBS+1% GPS (292 μg/ml Glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin) once to remove the surface blood. The specimens were digested with 0.2% collagenase A (Sigma, St. Louis, MO) in DMEM supplemented with 2% FBS and 1% GPS. After the digestion was completed, the tissue homogenate was filtered through a 100-μm cell strainer (BD, CA, USA). Red blood cells were lysed by incubating the sample in ammonium chloride (Sigma). Next, cells were filtered through a 40-μm strainer to get a single-cell suspension, and incubated with FITC-conjugated mouse anti-human PDGFRβ (BD Bioscience, San Jose, CA). The Hem-pericytes were purified by using a flow cytometer (BD Bioscience) to separate the PDGFRβ + cells. The purity of the Hem-pericytes was >95%, as determined by the positive SMA and smM-HC expression and the negative expression of CD31 (endothelial cells). Human retinal pericytes (RPCs) were obtained from Lonza (Allendale, NJ, USA). Primary HUVECs were obtained from the Chinese Academy of Sciences (Shanghai, China).
The coculture experiment was performed as previously described [21, 22] . The mRNA of the target genes expressed in IH tissues and Hem-pericytes was isolated using Trizol reagent (Invitrogen, Carlsbad, CA, USA) and reverse transcribed into cDNA. Quantitation of the relative mRNA abundance was performed using an ABI Prism 7700 Sequence Detection System (Applied Biosystems). The primers are listed in Table 2 .
RNA extraction and quantitative real-time PCR analysis
Immunofluorescence and double staining
The IH specimens were de-paraffinized, and avidin and biotin were added with the blocking agents. The blocking agent was blotted off, and the first antibody was added to incubate overnight at 4°C. The slides were washed and incubated with the second antibody at room temperature for 30 minutes. Images were acquired using a Leica microscope camera (Leica Microsystems, Wetezlar, Germany).
Western blot analysis
The protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electrophoretically transferred onto a nitrocellulose membrane. The protein bands were visualized using enhanced ECL-associated fluorography.
Results
Notch3, Hes1 and HEYL were highly expressed in involuting Hem-pericytes
Previous studies have demonstrated that the IH life-cycle is associated with clear spatialtemporal changes in the expression of Notch members [14, 15] . We analyzed the expression levels of Jagged1, Notch3, Hes1 and HEYL in proliferating and involuting IHs using real-time PCR (Fig. 1A and 1B) . Consistent with previous studies [15] , our data showed that the gene expression of Jagged1 in involuting IHs was significantly higher than that in proliferating IHs. We also observed upregulation of Hes1 and HEYL mRNA within involuting IHs compared with proliferating IHs (Fig. 1C) .
Jagged1 has been detected predominantly present in hemangioma ECs, whereas Notch3, Hes1 and HEYL are primarily expressed in hemangioma pericytes [15, 17] . We examined the expression of Notch genes in Hem-pericytes in vitro (Fig. 1D) . The Hem-pericyte lines that we used are derived from two proliferating and two involuting IHs. We designated these cells P-Hem-pericyte (proliferating) and I-Hem-pericyte (involuting). Real-time PCR showed that the I-Hem-pericytes exhibited higher gene expression levels of Notch3, Hes1 and HEYL than did P-Hem-pericytes and RPCs (Fig. 1E ).
Jagged1 activates Notch3 signaling in involuting Hem-pericytes
We next determined the effect of Jagged1 on Notch target gene mRNA levels in I-Hempericytes. Quantitative real-time PCR revealed a significant increase in Notch target gene mRNA levels (specifically, Hes1 and HEYL). In contrast, DAPT, a γ-secretase inhibitor that inhibits Notch receptor cleavage and thus NICD production, significantly attenuated Jagged1-induced Hes1 and HEYL gene expression ( Fig. 2A) . To further corroborate these findings, we targeted Notch3 by siRNA-mediated knockdown and compared the results to those of a scrambled siRNA control. Using real-time PCR and western blot analyses, we demonstrated successful knockdown of Notch3 expression in Hem-pericytes (Fig. 2B) . Knockdown of the Notch3 receptor significantly reduced the levels of Hes1 and HEYL transcripts that were induced by Jagged1 stimulation (Fig. 2C ).
Jagged1/Notch3 signaling inhibits involuting Hem-pericyte proliferation
Because of the observation that I-Hem-pericytes showed a significantly lower proliferation rate than P-Hem-pericytes both in vivo and in vitro [10] , we postulated that Notch signaling might be involved in Hem-pericyte proliferation. To test this hypothesis, we investigated whether increased activation of Notch signaling affected I-Hem-pericyte proliferation. Stimulation of Hem-pericyte with Jagged1 revealed a growth rate that was significantly slower than that of control at the pre-confluence, confluence and postconfluence stages, as indicated by the total cell numbers at different time points (Fig. 3A) . These data were confirmed by BrdU incorporation at the pre-confluence stage (Fig. 3B) .
We next examined whether Jagged1-induced cell growth arrest is dependent on the activation of the Notch3 pathway or on the proteolytic cleavage of signal-transducing NICD by γ-secretase. As shown in Fig. 3C , Jagged1-induced cell proliferation arrest was significantly rescued by knockdown of Notch3. Furthermore, similar results were obtained by treatment of Hem-pericytes with DAPT (Fig. 3D) . 
, p27
Kip1 , cyclin D1, CKD2, CDK4, CKD6 and phospho-Rb (n = 4). (C), Hem-pericytes were transfected with ntRNA or siRNA Table 3 . Effect of Jagged1/Notch3 on the cell cycle distribution of Hem-pericytes (mean ± SD, n = 6). *P<0.05 compared with the Fc treated control, † P<0.05 compared with the Jagged1 Fc group (ANOVA)
Table 4. Effect of p21
Cip1 on cell cycle of Hem-pericytes (mean ± SD, n = 6). * P<0.05 compared with the Jagged1 Fc + ntRNA group. (ANOVA)
Jagged1/Notch3 signaling inhibits cell cycle progression in involuting Hem-pericytes via the p21
Cip1 pathway. Hem-pericytes were plated on Jagged1 Fc or Fc control for 48 h, and the cell cycle distribution was analyzed using PI staining. As shown in Cip1 knockdown Hem-pericytes were placed on Fc or Jagged1 Fc for 48 h, and cell lysates were immunoblotted to detected cyclin D1, CDK4 and phospho-Rb (n = 4). the reduced cyclin D1 and CDK-4 expression as well as the decreased phosphorylation of Rb by Jagged1 activation was rescued by a lack of p21 Cip1 (Fig. 4F) .
Jagged1/Notch3 promotes involuting Hem-pericyte maturation
Compared with proliferating Hem-pericytes, involuting Hem-pericytes expressed higher levels of contractile markers for mature pericytes, including smMHC and αSMA (Fig.  5A , 5B and 5C). In Jagged1 Fc-stimulated cells, the expression of genes associated with the maturation/contractile phenotype, including smMHC and αSMA, were increased in compared with the Fc control cells (Fig. 5D) . We further confirmed that Jagged1 induced these pericyte/ SMC markers at the protein level (Fig. 5E ). However, under identical experimental conditions, knockdown of Notch3 abolished the Jagged1-induced smMHC and αSMA expression (Fig. 5D  and 5E ).
Pericytes and vSMCs belong to the same lineage and category [13] . We examined the expression of myocardin in IH tissues. Immunofluorescence studies showed that myocardin was expressed in perivascular regions and that it colocalized with αSMA ( Fig. 5F ). To investigate whether myocardin is involved in the Hem-pericyte fate, we examined myocardin levels in Hem-pericytes after Jagged1 activation. As shown in Fig. 5G , Jagged1 upregulated myocardin protein expression in Hem-pericytes. We further studied the requirement for HUVECs for 72 h, either as 2D cultures allowing for physical contact between Hem-pericytes and HUVECs or in transwell cultures where the two cell types were separated by a membrane (n = 6;*** P<0.001) (ANOVA). (C), Western blot analysis of smMHC and αSMA in cell lysates from Hem-pericytes cultured together with pCMV6-Entry HUVECs or pCMV6-Jagged1 HUVECs for 72 h. Western blot for GAPDH was used as a loading control (n = 4).
Notch3 for myocardin expression induced by Jagged1. Western blotting for myocardin revealed that Notch3 knockdown resulted in reduced myocardin expression in response to Jagged1.
Endothelial-derived Jagged1 modulates involuting Hem-pericyte phenotype via a cell contact-dependent mechanism As mentioned previously, Jagged1 is primarily expressed in IH ECs [15] . We transfected HUVECs with an expression plasmid for Jagged1 (Fig. 6A ) and cocultured them with Hempericytes. After 72 h, Hem-pericytes and HUVECs were separated by fluorescence-activated cell sorting (FACS) based on CD31 expression in the HUVECs. We confirmed that endothelialderived Jagged1 is biologically active because it induced the expression of Hes1 and HEYL in Hem-pericytes. Of particular important, EC-derived Jagged1 obviously repressed PCNA expression and induced smMHC and αSMA expression in Hem-pericytes (Fig. 6B and 6C) . Using a transwell coculture system, we assessed the need for physical contact for the ECdependent regulation of genes in Hem-pericytes. Separation of Hem-pericytes and HUVECs by a membrane permeable to proteins, but not cells, rendered HUVECs unable to induce Hes1 and HEYL expression in Hem-pericytes (Fig. 6B) . Furthermore, we observed no changes in PCNA, smMHC or αSMA expression in Hem-pericytes after transwell coculture with HUVECs ( Fig. 6B and 6C ).
Discussion
Interestingly, studies investigating the function of Notch signaling in pericyte/vSMC have yielded conflicting results, describing both anti-proliferation and pro-proliferation functions as well as both anti-maturation and pro-maturation functions for Notch [26, 27] . These discrepancies have been speculated to be a result of the highly context-dependent nature and tight spatio-temporal regulation of Notch pathway components during vascular development [9] . In the present study, Jagged1 stimulation resulted in activation of Notch3 in Hem-pericytes concomitant with growth arrest, contractile marker expression and pericyte maturation. In contrast, inhibition of Notch3 signaling using both pharmacological and molecular interventions reversed these effects of Jagged1. These findings provided substantial new evidence that Jagged1/Notch3 signaling activation may be required for the establishments of a mature, quiescent Hem-pericyte phenotype. Our observations raise the intriguing possibility that in the involuting phase, upregulated Notch signaling in Hempericytes could have an pro-quiescent effect on hemangiomagenesis and, therefore, on hemangioma regression.
The p21 Cip1 and p27 Kip1 proteins inactivate the cyclin-CDK complexes in G 1 leading to cell cycle arrest, and therefore, they function in pericyte/cSMC growth regulation. Notch signaling has significant effect on p21
Cip1 and p27 kip1 activity and cell cycle progression, thus having implications for growth dysregulation in vascular disease and cell transformation [28] . Our studies showed an increased expression of p21
Cip1 upon Jagged1 stimulation and a decreased expression of p21 Cip1 by knockdown of Notch3 in Hem-pericyte, implying that p21
Cip1 has a role in Hem-pericyte proliferation. Furthermore, we provided direct evidence indicating that one mechanism through which Jagged1/Notch3 interferes with the cell cycle machinery in Hem-pericytes is the upregulation of p21
Cip1
, which impairs the capacity of Hem-pericytes to enter S phase. Interestingly, we did observe the induction of p27 kip1 following Notch stimulation of Hem-pericytes, further supporting the idea of cell-specific activation of Notch effector molecules [29] .
There is compelling evidence that most pericyte/SMC markers are controlled by serum response factor (SRF), which binds to a sequence known as a CArG box and recruits a potent coactivator, myocardin, for pericyte/SMC differentiation and maturation [9, 13] . Mouse embryos deficient in myocardin show no evidence of vSMC, indicating that myocardin is a necessary and sufficient factor for vSMC development in vivo [30] . Depending on the cell type and context, the Notch pathway can generate either an inhibitory or promotional effect on myocardin expression, thus mediating vSMC differentiation and maturation [31, 32] . Furthermore, Notch and myocardin can synergistically induce vSMC differentiation and maturation [33] . In the present study, we were intrigued by these distinguishing features and demonstrated that activation of Jagged1/Notch3 signaling was sufficient to promote a contractile phenotypic maturation that was characterized by increased smMHC and αSMA expression. Importantly, the expression level of smMHC, the most reliable marker for pericyte/vSMC, was upregulated by Notch, strongly suggesting that Notch induces Hempericyte maturation, not merely several pericyte markers. These observations, together with the findings that Notch upregulated myocardin expression in Hem-pericytes, highlight a potential mechanism whereby the activation of Jagged1/Notch3, via regulation of the myocardin pathway, promotes Hem-pericyte maturation.
The differentiation of mature Hem-pericyte from their progenitors, HemSCs, may involve a series of steps. Previously, Boscolo et al. [18] showed that endothelial-derived Jagged-1 was sufficient to stimulate HemSCs to differentiate toward a pericyte-like phenotype, suggesting that Notch plays a positive role in the vasculogenic process, with angiogenic sprouting as secondary event. However, in a different study, very few HemSCs were detected in the involuting phase of IH [34] . In this regard, it is plausible that Notch signaling, including possible augmentation of other signaling pathways (e.g., myocardin), not only plays a fundamental role in the formation of blood vessels in early proliferating IH but is also required to promote maturation of the vasculature in involuting IH. Further investigation is needed to conclusively identify the specific function of Notch in different stages of vascular remodeling in IHs.
Solid evidence has emerged supporting a pivotal role for Notch receptor/ligands in mediating EC in pericyte communication and influencing the phenotypic state of pericyte or vice versa [35, 36] . We proceeded based on our previous supposition that the Notch pathway might also contribute to establishing two distinct subpopulations at different steps of angiogenesis in IHs, such as ECs versus pericytes [29, 37, 38] . We demonstrated that the Jagged1 level was increased in involuting IH tissues [15] . These observations, coupled with the findings from our coculture studies, highlight the potential role of endothelial-derived Jagged1 in transducing Hem-pericyte Notch receptor. Furthermore, we found that ECs need to be in apposition to pericytes to confer induction of Hes1 and HEYL. It may be that actual physical contact between Hem-pericytes and ECs is needed in the context of vascular remodeling [39] .
Conclusion
In conclusion, we have demonstrated that Notch3 and its target genes are upregulated within involuting Hem-pericytes. Jagged1 activation of Notch3 reduces Hem-pericyte proliferation and maintains the cells in the G 0 /G 1 phase, at least in part, by the stimulation of p21
Cip1 production. Furthermore, Jagged1/Notch3 signaling constitutes an instructive signal for Hem-pericyte maturation, associated with an increase in the expression of myocardin. Our data provide a mechanism by which Jagged1/Notch3 signaling contributes to the quiescent and contractile phenotype of involuting Hem-pericyte.
